Stephen V Liu/X
Aug 13, 2025, 15:15
Stephen V Liu: Comparison of EGFR NSCLC Transformed to SCLC vs de novo SCLC
Stephen V Liu, Director of Thoracic Oncology, Chief, Division of Hematology and Oncology, and Associate Professor at Georgetown Lombardi Comprehensive Cancer Center, shared a post on X:
“Comparison of EGFR NSCLC transformed to SCLC vs de novo SCLC. OS shorter with transformed SCLC esp with high neuroendocrine marker expression. In transformed SCLC, OS with chemo-immunotherapy superior to chemo +/- TKI (15.4m vs 8.5m).”
Title: Clinical outcomes and neuroendocrine features of transformed versus primary small-cell lung cancer
Authors: Lina Chen, Xiu-Hao Zhang, Zi-Ji Mao, Dan Wang, Chan-Yuan Zhang, Hua-Jun Chen, Yi-Long Wu, Jin-Ji Yang
Read the Full Article.
More posts featuring Stephen Liu.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 14, 2025, 03:06
Aug 14, 2025, 03:04
Aug 13, 2025, 21:09
Aug 13, 2025, 20:52
Aug 13, 2025, 20:36